Which Endpoints Should We Use in Evaluating the Use of Novel Fluoropyrimidine Regimens in Colorectal Cancer?

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600341
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Which Measure of Aggregate Output Should We Use?

Journal of Macroeconomics
EconomicsEconometrics
2000English

The Top-Down Approach to Measurement Uncertainty: Which Formula Should We Use in Laboratory Medicine?

Biochemia Medica
BiochemistryClinical Biochemistry
2020English

A Framework Within Which to Determine How We Should Use Animals in Science Education

Animals and Science Education
2017English

Should We Use Antifibrinolytic Agents in Lower Limb

Orthopedic & Muscular System
2012English

Biodiversity: What Value Should We Use?

Frontiers in Ecology and the Environment
EvolutionEcologySystematicsBehavior
2017English

Should We Recriminalize Cannabis Use? The Case Against

Canadian Journal of Psychiatry
PsychiatryMental Health
2008English

What Should We Do About Habitual Caffeine Use in Athletes?

Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2018English

Choropleth Map – Which Data Type Should I Use?

Abstracts of the ICA
2019English

Should We Use Commitment Contracts to Regulate Student Use of Cognitive Enhancing Drugs?

Bioethics
Health PolicyPhilosophyHealth
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy